Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. BioPlus Acquisition Corp
BIOS

Buy BIOS Stock

BIOS
See BIOS stock price and Buy/Sell BioPlus Acquisition Corp with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
BIOS

BioPlus Acquisition Corp (BIOS)

About BioPlus Acquisition Corp (BIOS)

BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying an opportunity in the life sciences industry. The company was founded on February 11, 2021 and is headquartered in New York, NY.
Market Cap
$293.1M
1 Year High
$10.01
Volume
1 Year Low
$9.78
Price to Earnings Ratio
Open
$10
Dividend Rate
High
$9.98
Dividend Yield
Low
$9.98

Community

People who own or watch BIOS stock

BIOS Stock News

BIOS stock rating

What analysts recommend for BIOS stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell

BIOS price target

What analysts think BIOS will be worth
Low $0
High $10.01
Current $9.98
Target $0

BIOS earnings

The value each share was expected to gain vs. the value that each share actually gained
0.25
0.16
0.08
0
Q2 2021
Q3 2021
Q4 2021
Q1 2022

Expected EPS
Q1 2022
$0.16
Actual EPS
Q1 2022

Buy BIOS Stock

BIOS
See BIOS stock price and Buy/Sell BioPlus Acquisition Corp with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch BIOS stock
  • ST1C1T2U avatar
  • williamsoucy321 avatar
  • untamedshane avatar
  • mauro5607 avatar
  • demerith avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.